Search research articles
Contact Us
Filters
Showing results (111-120 of 234) with videos related to
Page
of 24
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 16, 2010
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS
Borje S Andersson, Benigno C Valdez, Marcos de Lima, et al.
Bone Marrow Transplantation
|
October 20, 2018
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation
Mithun Vinod Shah, Rima M Saliba, Gabriela Rondon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 27, 2007
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan
Betul Oran, Sergio Giralt, Rima Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 2, 2008
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial
Muzaffar H Qazilbash, Rima M Saliba, Yago Nieto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 7, 2012
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome
Yago Nieto, Uday Popat, Paolo Anderlini, et al.
British Journal of Haematology
|
June 20, 2008
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation
Amin M Alousi, Rima M Saliba, Grace-Julia Okoroji, et al.
Blood
|
January 27, 2009
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma
Constantine S Tam, Roland Bassett, Celina Ledesma, et al.
Transplantation and Cellular Therapy
|
September 24, 2023
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative Conditioning
Jacinth Joseph, Samer A Srour, Denái R Milton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2018
Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers
Vivek Subbiah, Ravi Murthy, David S Hong, et al.
Cancer
|
October 15, 2016
Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents
Elias Jabbour, Stefan Faderl, Koji Sasaki, et al.
Page
of 24
Search research articles
Search
Showing results (111-120 of 234) with videos related to
Sort By:
Page
of 24
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 16, 2010
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS
Borje S Andersson, Benigno C Valdez, Marcos de Lima, et al.
Bone Marrow Transplantation
|
October 20, 2018
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation
Mithun Vinod Shah, Rima M Saliba, Gabriela Rondon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 27, 2007
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan
Betul Oran, Sergio Giralt, Rima Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 2, 2008
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial
Muzaffar H Qazilbash, Rima M Saliba, Yago Nieto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 7, 2012
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome
Yago Nieto, Uday Popat, Paolo Anderlini, et al.
British Journal of Haematology
|
June 20, 2008
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation
Amin M Alousi, Rima M Saliba, Grace-Julia Okoroji, et al.
Blood
|
January 27, 2009
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma
Constantine S Tam, Roland Bassett, Celina Ledesma, et al.
Transplantation and Cellular Therapy
|
September 24, 2023
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative Conditioning
Jacinth Joseph, Samer A Srour, Denái R Milton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2018
Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers
Vivek Subbiah, Ravi Murthy, David S Hong, et al.
Cancer
|
October 15, 2016
Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents
Elias Jabbour, Stefan Faderl, Koji Sasaki, et al.
Page
of 24